Browsing by Author "García-Flores, Valeria"

Now showing 1 - 2 of 2
  • No Thumbnail Available
    Item
    Homeostatic Macrophages Prevent Preterm Birth and Improve Neonatal Outcomes by Mitigating In Utero Sterile Inflammation in Mice
    (2024) García-Flores, Valeria; Liu, Zhenjie; Romero, Roberto; Pique-Regi, Roger; Xu, Yi; Miller, Derek; Levenson, Dustyn; Galaz Alarcón, José Carlo; Winters, Andrew D.; Farias Jofré, Marcelo Enrique; Panzer, Jonathan J.; Theis, Kevin R.; Gómez-López, Nardhy
    Copyright © 2024 by The American Association of Immunologists, Inc.Preterm birth (PTB), often preceded by preterm labor, is a major cause of neonatal morbidity and mortality worldwide. Most PTB cases involve intra-amniotic inflammation without detectable microorganisms, termed in utero sterile inflammation, for which there is no established treatment. In this study, we propose homeostatic macrophages to prevent PTB and adverse neonatal outcomes caused by in utero sterile inflammation. Single-cell atlases of the maternal-fetal interface revealed that homeostatic maternal macrophages are reduced with human labor. M2 macrophage treatment prevented PTB and reduced adverse neonatal outcomes in mice with in utero sterile inflammation. Specifically, M2 macrophages halted premature labor by suppressing inflammatory responses in the amniotic cavity, including inflammasome activation, and mitigated placental and offspring lung inflammation. Moreover, M2 macrophages boosted gut inflammation in neonates and improved their ability to fight systemic bacterial infections. Our findings show that M2 macrophages are a promising strategy to mitigate PTB and improve neonatal outcomes resulting from in utero sterile inflammation.
  • No Thumbnail Available
    Item
    Homeostatic Macrophages Prevent Preterm Birth and Improve Neonatal Outcomes by Mitigating In Utero Sterile Inflammation in Mice
    (2024) García-Flores, Valeria; Liu, Zhenjie; Romero, Roberto; Pique-Regi, Roger; Xu, Yi; Miller, Derek; Levenson, Dustyn; Galaz Alarcón, José Carlo; Winters, Andrew D.; Farias Jofré, Marcelo Enrique; Panzer, Jonathan J.; Theis, Kevin R.; Gómez-López, Nardhy
    Preterm birth (PTB), often preceded by preterm labor, is a major cause of neonatal morbidity and mortality worldwide. Most PTB cases involve intra-amniotic inflammation without detectable microorganisms, termed in utero sterile inflammation, for which there is no established treatment. In this study, we propose homeostatic macrophages to prevent PTB and adverse neonatal outcomes caused by in utero sterile inflammation. Single-cell atlases of the maternal-fetal interface revealed that homeostatic maternal macrophages are reduced with human labor. M2 macrophage treatment prevented PTB and reduced adverse neonatal outcomes in mice with in utero sterile inflammation. Specifically, M2 macrophages halted premature labor by suppressing inflammatory responses in the amniotic cavity, including inflammasome activation, and mitigated placental and offspring lung inflammation. Moreover, M2 macrophages boosted gut inflammation in neonates and improved their ability to fight systemic bacterial infections. Our findings show that M2 macrophages are a promising strategy to mitigate PTB and improve neonatal outcomes resulting from in utero sterile inflammation.